Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of a compound of this kind, a pharmaceutical composition comprising at least said compound, for use thereof as a drug for causing regression of a mammalian cancerous tumor.

Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of such a compound, to a pharmaceutical composition comprising at least said compound, for its use as a medicament for shrinking a mammalian cancerous tumor.

Abstract: A composition comprising sterol derivatives for use in the treatment of a neuronal pathology related to hypoxia, hypoglycemia and/or hyperglycemia affecting cells of the central nervous system.

Abstract: The invention relates to a frozen dessert, which, independently of any incorporation of gas, is malleable and extrudable at the freezing temperatures. This dessert includes water, proteins, fat, sweetening agents and at least one stabilizing agent, with the sweetening agents forming a mixture which contains glucose and optionally fructose. These two compounds constitute, as a whole, from 6 to 30% of the total weight of the composition. The frozen dessert includes a nucleating agent, in particular microcrystalline cellulose. The invention relates, in addition, to a process for producing such a dessert, such a packaged dessert and a container for its packaging and its distribution.

Abstract: A frozen dessert which is spoonable at freezing temperatures and/or packageable in pressurized containers is disclosed. The frozen dessert has dairy proteins, fats, sweeteners, one or more stabilizing agents, flavoring agents or coloring agents. The proteins are provided by dairy milk products or skimmed milk. The fat is a vegetable oil with a very low freezing point. The sweeteners are a mixture of low molecular weight sweetening agents such as dextrose and/or fructose, invert sugar and glucose syrup.